Not exact matches
The current method of prescribing medication now sometimes includes a
pharmacogenomic approach, but researchers recognize the limitation of this approach in predicting a response to a particular
drug and dosage combination.
Pharmacogenomics — Personalized Drugs, Personalized Careers Even in one of the worst years ever for employment in the biotech industry, according to Jim Kling, pharmacogenomics trainees find themselves with abundan
Pharmacogenomics — Personalized
Drugs, Personalized Careers Even in one of the worst years ever for employment in the biotech industry, according to Jim Kling,
pharmacogenomics trainees find themselves with abundan
pharmacogenomics trainees find themselves with abundant opportunities.
From the very first collaborations with companies doing
pharmacogenomic analyses on new
drugs, he has had to abide by strict agreements of confidentiality.
That's why some AD researchers are turning to
pharmacogenomics: the study of how genes influence the way we respond to
drugs.
As a member of their scientific advisory boards, he helps the study directors design the
pharmacogenomic portion of new clinical
drug trials.
«What most pharma look to me for is my 10 years of experience in
pharmacogenomic clinical
drug trial design and result interpretation,» he explains.
And most of the time,
pharmacogenomics is one of a series of tools — albeit a crucial one — that researchers use to investigate how patients respond to
drugs, and the mechanisms of
drugs and
drug interactions.
He also analyzes the
pharmacogenomic data and their potential impact on
drug approval and commercial sales.
Pharmacogenomics — the study of how genes affect responses to
drugs — is becoming more important in
drug - development research and clinical trials, with a view toward decreasing side effects and increasing the efficiency and efficacy of
drugs in patients with the right genetic profiles.
Drug companies were much in evidence at the convention, and if there is one area of genomics that has attracted a critical mass of believers, it's
pharmacogenomics.
It also alludes to the complex phenotypes and rare
drug outcomes resulting from rare
pharmacogenomic variants.
Pharmacogenomics aims to rationalize
drug use by minimizing
drug toxicity and / or by increasing...
The DrugeVar database, an online database triangulating
drugs with genes and
pharmacogenomics...
Themed «Rare Genomics: Genomics of Rare Diseases, Rare Cancers and rare
Drug Outcomes», this international scientific event will revolve around the application of the most important disciplines of Genomic Medicine, such as Genome discovery, informatics, Public Health, and drug design in Rare Diseases, Cancer and Pharmacogenom
Drug Outcomes», this international scientific event will revolve around the application of the most important disciplines of Genomic Medicine, such as Genome discovery, informatics, Public Health, and
drug design in Rare Diseases, Cancer and Pharmacogenom
drug design in Rare Diseases, Cancer and
Pharmacogenomics.
Lastly, this part summarizes the various regulatory aspects of
pharmacogenomics and their role in
drug development.
Results of this study has shown that there is a significant inter-population variability, as far as
pharmacogenomic biomarker allele frequency is concerned, which has a direct impact on the rationalization of
drug use at a population level.
The process they have followed in order to gather the specific information was to extract from the published literature all
pharmacogenomic biomarkers that relate to the US Food and
Drug Administration (FDA) and the European Medicines Agency (EMA) approved
drugs with
pharmacogenomic information in their label and make them available in a database that triangulates between
drugs, genes and
pharmacogenomics biomarkers.
Members of the Genome Informatics Working Group have recognized the need to provide a comprehensive resource for
pharmacogenomic biomarkers information for those
drugs that are approved by regulatory authorities.
A
pharmacogenomic method for individualized prediction of
drug sensitivity.
Bringing together a patient's genetic test results and relating those to clinical, published knowledge about
pharmacogenomic relevance, explained O'Donnell, the portal gives physicians instant access to
drug risks or benefits specific to an individual's genotype.
Pharmacogenomics, the study of how an individual's genetic variations impact the response to
drugs, has emerged as an essential tool to optimize therapy and minimize the risk of adverse effects.
An online resource triangulating
drugs with genes and biomarkers for clinical
pharmacogenomics.
It is expected that
pharmacogenomics is most likely cost - effective, since it reduces the incidence of adverse
drug reactions, which can reciprocally reduce healthcare expenditure at the national level.
One of the most important prerequisites of the successful implementation of
pharmacogenomics into the clinic is the increase of the general public's awareness over the benefits of
pharmacogenomics in rationalising
drug use.
Pharmacogenomics of NAT2 influences Oral Anti Tuberculosis
Drug Induced Hepatotoxicity in Indonesia
Clinical application of
pharmacogenomics knowledge will result in less «trial and error» prescribing and more efficacious, safer and cost - effective
drug therapy.
The Sections aims are, to promote the exchange of pharmacogenetic knowledge by organization of symposia and workshops in the field of pharmacogenetics and genomics, to evaluate the clinical impact of pharmacogenetics, to assist with the development and maintenance of
drug - related pharmacogenetic databases and to create a population based biobank to conduct translational research in clinical
pharmacogenomics.
Hakonarson H and Stefansson K Role of
pharmacogenomics in
drug development Drug Development Research 2004 62 (2): 86
drug development
Drug Development Research 2004 62 (2): 86
Drug Development Research 2004 62 (2): 86 - 96
-- search and browse through established
pharmacogenomic gene - variant -
drug - metabolizer status associations; (2)
For example, it is used to identify correlations between gene sequences and diseases, to predict protein structures from amino acid sequences, to aid in the design of novel
drugs, and to tailor treatments to individual patients based on their DNA sequences (
pharmacogenomics).
Fifty - one of the 71 cardiovascular
drugs they focused on (71.8 percent) had detectable
pharmacogenomic effects.
«I have long been familiar with the common variations in response to
drugs, but, like most physicians in my specialty, I had limited knowledge of the
pharmacogenomics behind it, or the ability of this information to predict a problem.»
Pharmacogenomics Knowledge Base; curated and annotated information regarding the effects of human genetic variations on
drug response.
To help physicians make better - informed clinical decisions, researchers from the University of Chicago and Stanford University combed through scientific literature on the
pharmacogenomics of 71 leading cardiovascular
drugs and compiled summaries, published in the June issue of the Mayo Clinic Proceedings.
With its uniquely comprehensive population data, deCODE is turning research on the genetic causes of common diseases into a growing pipeline of products and services — in pharmaceuticals, gene and
drug discovery, DNA - based diagnostics,
pharmacogenomics, bioinformatics, and clinical trials.
To provide insight on the utility and practicality of implementing a pharmacist - driven
pharmacogenomics program in a community pharmacy or primary care setting and to provide a clinical update on common
drug - gene implications using clinical case vignettes.